For press inquiries click here to contact us.
FierceBiotech
Grail’s third VC round brings funding total to $1.5B
Xconomy
ORIC Pharmaceuticals Appoints Jacob Chacko CEO
San Francisco Business Times
‘Bursting at the seams,’ this high-profile Peninsula biotech company is moving to a bigger home
FierceBiotech
Loxo RET inhibitor shines in early-phase trial
STAT
A much-needed sickle cell drug reaches a critical readout. Here’s what you need to know
CNN Money
Are you at risk for cancer? This startup CEO wants to help you find out
GenomeWeb
NanoString Announces Digital Spatial Profiling Deals With Several CROs
Science AAAS
Blood test shows promise for spotting early cancers
Forbes
Blueprint Medicines’ Cancer Drug Impresses In Early Study
Please see important disclaimers in the Terms section.
